Should low-risk DCIS lose the cancer label? An evidence review
ConclusionEpidemiological evidence supports consideration of relabelling and/or recalibrating diagnostic thresholds for low-risk DCIS. Such diagnostic changes would need agreement on the definition of low-risk DCIS and improved diagnostic reproducibility.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Databases & Libraries | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Epidemiology | Mammography | Pathology | Study | Women